The long-acting glucagon-like peptide-1 analogue, liraglutide, inhibits β-cell apoptosis in vitro
- 11 March 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 330 (2), 577-584
- https://doi.org/10.1016/j.bbrc.2005.03.013
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Glucagon-like Peptide-1 Receptor Signaling Modulates β Cell ApoptosisJournal of Biological Chemistry, 2003
- Diseases of liporegulation: new perspective on obesity and related disordersThe FASEB Journal, 2001
- GLP-1 derivatives as novel compounds for the treatment of type 2 diabetes: Selection of NN2211 for clinical developmentDrugs of the Future, 2001
- Rapid Activation of Protein Kinase B/Akt Has a Key Role in Antiapoptotic Signaling during Liver RegenerationBiochemical and Biophysical Research Communications, 2000
- Integrative Mitogenic Role of Protein Kinase B/Akt in β‐CellsAnnals of the New York Academy of Sciences, 2000
- The Glucagon-like Peptide-2 Receptor Mediates Direct Inhibition of Cellular Apoptosis via a cAMP-dependent Protein Kinase-independent PathwayJournal of Biological Chemistry, 2000
- Apoptosis SignalingAnnual Review of Biochemistry, 2000
- Serine/Threonine Protein Kinases and ApoptosisExperimental Cell Research, 2000
- ENTEROGLUCAGONAnnual Review of Physiology, 1997
- Glucose-Dependent Insulinotropic Polypeptide Stimulates Insulin Secretion via Increased Cyclic AMP and [Ca2+]iand a Wortmannin-Sensitive Signalling PathwayBiochemical and Biophysical Research Communications, 1996